Satish  Nadig  to  Reperfusion Injury
                            
                            
                                This is a "connection" page, showing publications  Satish  Nadig  has written about  Reperfusion Injury.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            2.005
         
        
        
     
 
    
        
        - 
            Connexins in endothelial cells as a therapeutic target for solid organ transplantation. Am J Transplant. 2022 Nov; 22(11):2502-2508.
            
            
                Score: 0.638
             
- 
            Impact of Mitochondrial Permeability on Endothelial Cell Immunogenicity in Transplantation. Transplantation. 2018 06; 102(6):935-944.
            
            
                Score: 0.483
             
- 
            Hepatocellular ultrastructure after ischemia/reperfusion injury in human orthotopic liver transplantation. J Gastrointest Surg. 2004 Sep-Oct; 8(6):695-700.
            
            
                Score: 0.186
             
- 
            Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation. Front Immunol. 2021; 12:785229.
            
            
                Score: 0.154
             
- 
            In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries. Front Immunol. 2021; 12:630581.
            
            
                Score: 0.150
             
- 
            A novel injury site-natural antibody targeted complement inhibitor protects against lung transplant injury. Am J Transplant. 2021 06; 21(6):2067-2078.
            
            
                Score: 0.146
             
- 
            Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury. Am J Respir Cell Mol Biol. 2019 06; 60(6):678-686.
            
            
                Score: 0.129
             
- 
            Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant. Am J Transplant. 2018 10; 18(10):2417-2428.
            
            
                Score: 0.119